Pulmonary morbidity in infancy after exposure to chorioamnionitis in late preterm infants

Karen M. McDowell, Alan H. Jobe, Matthew Fenchel, William D. Hardie, Tate Gisslen, Lisa R. Young, Claire A. Chougnet, Stephanie Davis, Suhas G. Kallapur

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Rationale: Chorioamnionitis is an important cause of preterm birth, but its impact on postnatal outcomes is understudied. Objectives: To evaluate whether fetal exposure to inflammation is associated with adverse pulmonary outcomes at 6 to 12 months' chronological age in infants born moderate to late preterm. Methods: Infants born between 32 and 36 weeks' gestational age were prospectively recruited (N = 184). Chorioamnionitis was diagnosed by placenta and umbilical cord histology. Select cytokines were measured in samples of cord blood. Validated pulmonary questionnaires were administered (n = 184), and infant pulmonary function testing was performed (n = 69) between 6 and 12 months' chronological age by the raised volume rapid thoracoabdominal compression technique. Measurements and Main Results: A total of 25% of participants had chorioamnionitis. Although infant pulmonary function testing variables were lower in infants born preterm compared with historical normative data for term infants, there were no differences between infants with chorioamnionitis (n = 20) and those without (n = 49). Boys and black infants had lower infant pulmonary function testing measurements than girls and white infants, respectively. Chorioamnionitis exposure was associated independently with wheeze (odds ratio [OR], 2.08) and respiratory-related physician visits (OR, 3.18) in the first year of life. Infants exposed to severe chorioamnionitis had increased levels of cord blood IL-6 and greater pulmonary morbidity at age 6 to 12 months than those exposed to mild chorioamnionitis. Elevated IL-6 was associated with significantly more respiratory problems (OR, 3.23). Conclusions: In infants born moderate or late preterm, elevated cord blood IL-6 and exposure to histologically identified chorioamnionitis was associated with respiratory morbidity during infancy without significant changes in infant pulmonary function testing measurements. Black compared with white and boy compared with girl infants had lower infant pulmonary function testing measurements and worse pulmonary outcomes.

Original languageEnglish (US)
Pages (from-to)867-876
Number of pages10
JournalAnnals of the American Thoracic Society
Volume13
Issue number6
DOIs
StatePublished - Jun 1 2016

Fingerprint

Chorioamnionitis
Premature Infants
Morbidity
Lung
Fetal Blood
Interleukin-6
Odds Ratio
Umbilical Cord
Premature Birth
Placenta

Keywords

  • Asthma
  • Fetal inflammation
  • Fetal programming
  • Infant pulmonary function test
  • Wheeze

ASJC Scopus subject areas

  • Medicine(all)
  • Pulmonary and Respiratory Medicine

Cite this

McDowell, K. M., Jobe, A. H., Fenchel, M., Hardie, W. D., Gisslen, T., Young, L. R., ... Kallapur, S. G. (2016). Pulmonary morbidity in infancy after exposure to chorioamnionitis in late preterm infants. Annals of the American Thoracic Society, 13(6), 867-876. https://doi.org/10.1513/AnnalsATS.201507-411OC

Pulmonary morbidity in infancy after exposure to chorioamnionitis in late preterm infants. / McDowell, Karen M.; Jobe, Alan H.; Fenchel, Matthew; Hardie, William D.; Gisslen, Tate; Young, Lisa R.; Chougnet, Claire A.; Davis, Stephanie; Kallapur, Suhas G.

In: Annals of the American Thoracic Society, Vol. 13, No. 6, 01.06.2016, p. 867-876.

Research output: Contribution to journalArticle

McDowell, KM, Jobe, AH, Fenchel, M, Hardie, WD, Gisslen, T, Young, LR, Chougnet, CA, Davis, S & Kallapur, SG 2016, 'Pulmonary morbidity in infancy after exposure to chorioamnionitis in late preterm infants', Annals of the American Thoracic Society, vol. 13, no. 6, pp. 867-876. https://doi.org/10.1513/AnnalsATS.201507-411OC
McDowell, Karen M. ; Jobe, Alan H. ; Fenchel, Matthew ; Hardie, William D. ; Gisslen, Tate ; Young, Lisa R. ; Chougnet, Claire A. ; Davis, Stephanie ; Kallapur, Suhas G. / Pulmonary morbidity in infancy after exposure to chorioamnionitis in late preterm infants. In: Annals of the American Thoracic Society. 2016 ; Vol. 13, No. 6. pp. 867-876.
@article{5694bc8ab4ab45c4a97cb87384b04d83,
title = "Pulmonary morbidity in infancy after exposure to chorioamnionitis in late preterm infants",
abstract = "Rationale: Chorioamnionitis is an important cause of preterm birth, but its impact on postnatal outcomes is understudied. Objectives: To evaluate whether fetal exposure to inflammation is associated with adverse pulmonary outcomes at 6 to 12 months' chronological age in infants born moderate to late preterm. Methods: Infants born between 32 and 36 weeks' gestational age were prospectively recruited (N = 184). Chorioamnionitis was diagnosed by placenta and umbilical cord histology. Select cytokines were measured in samples of cord blood. Validated pulmonary questionnaires were administered (n = 184), and infant pulmonary function testing was performed (n = 69) between 6 and 12 months' chronological age by the raised volume rapid thoracoabdominal compression technique. Measurements and Main Results: A total of 25{\%} of participants had chorioamnionitis. Although infant pulmonary function testing variables were lower in infants born preterm compared with historical normative data for term infants, there were no differences between infants with chorioamnionitis (n = 20) and those without (n = 49). Boys and black infants had lower infant pulmonary function testing measurements than girls and white infants, respectively. Chorioamnionitis exposure was associated independently with wheeze (odds ratio [OR], 2.08) and respiratory-related physician visits (OR, 3.18) in the first year of life. Infants exposed to severe chorioamnionitis had increased levels of cord blood IL-6 and greater pulmonary morbidity at age 6 to 12 months than those exposed to mild chorioamnionitis. Elevated IL-6 was associated with significantly more respiratory problems (OR, 3.23). Conclusions: In infants born moderate or late preterm, elevated cord blood IL-6 and exposure to histologically identified chorioamnionitis was associated with respiratory morbidity during infancy without significant changes in infant pulmonary function testing measurements. Black compared with white and boy compared with girl infants had lower infant pulmonary function testing measurements and worse pulmonary outcomes.",
keywords = "Asthma, Fetal inflammation, Fetal programming, Infant pulmonary function test, Wheeze",
author = "McDowell, {Karen M.} and Jobe, {Alan H.} and Matthew Fenchel and Hardie, {William D.} and Tate Gisslen and Young, {Lisa R.} and Chougnet, {Claire A.} and Stephanie Davis and Kallapur, {Suhas G.}",
year = "2016",
month = "6",
day = "1",
doi = "10.1513/AnnalsATS.201507-411OC",
language = "English (US)",
volume = "13",
pages = "867--876",
journal = "Annals of the American Thoracic Society",
issn = "2325-6621",
publisher = "American Thoracic Society",
number = "6",

}

TY - JOUR

T1 - Pulmonary morbidity in infancy after exposure to chorioamnionitis in late preterm infants

AU - McDowell, Karen M.

AU - Jobe, Alan H.

AU - Fenchel, Matthew

AU - Hardie, William D.

AU - Gisslen, Tate

AU - Young, Lisa R.

AU - Chougnet, Claire A.

AU - Davis, Stephanie

AU - Kallapur, Suhas G.

PY - 2016/6/1

Y1 - 2016/6/1

N2 - Rationale: Chorioamnionitis is an important cause of preterm birth, but its impact on postnatal outcomes is understudied. Objectives: To evaluate whether fetal exposure to inflammation is associated with adverse pulmonary outcomes at 6 to 12 months' chronological age in infants born moderate to late preterm. Methods: Infants born between 32 and 36 weeks' gestational age were prospectively recruited (N = 184). Chorioamnionitis was diagnosed by placenta and umbilical cord histology. Select cytokines were measured in samples of cord blood. Validated pulmonary questionnaires were administered (n = 184), and infant pulmonary function testing was performed (n = 69) between 6 and 12 months' chronological age by the raised volume rapid thoracoabdominal compression technique. Measurements and Main Results: A total of 25% of participants had chorioamnionitis. Although infant pulmonary function testing variables were lower in infants born preterm compared with historical normative data for term infants, there were no differences between infants with chorioamnionitis (n = 20) and those without (n = 49). Boys and black infants had lower infant pulmonary function testing measurements than girls and white infants, respectively. Chorioamnionitis exposure was associated independently with wheeze (odds ratio [OR], 2.08) and respiratory-related physician visits (OR, 3.18) in the first year of life. Infants exposed to severe chorioamnionitis had increased levels of cord blood IL-6 and greater pulmonary morbidity at age 6 to 12 months than those exposed to mild chorioamnionitis. Elevated IL-6 was associated with significantly more respiratory problems (OR, 3.23). Conclusions: In infants born moderate or late preterm, elevated cord blood IL-6 and exposure to histologically identified chorioamnionitis was associated with respiratory morbidity during infancy without significant changes in infant pulmonary function testing measurements. Black compared with white and boy compared with girl infants had lower infant pulmonary function testing measurements and worse pulmonary outcomes.

AB - Rationale: Chorioamnionitis is an important cause of preterm birth, but its impact on postnatal outcomes is understudied. Objectives: To evaluate whether fetal exposure to inflammation is associated with adverse pulmonary outcomes at 6 to 12 months' chronological age in infants born moderate to late preterm. Methods: Infants born between 32 and 36 weeks' gestational age were prospectively recruited (N = 184). Chorioamnionitis was diagnosed by placenta and umbilical cord histology. Select cytokines were measured in samples of cord blood. Validated pulmonary questionnaires were administered (n = 184), and infant pulmonary function testing was performed (n = 69) between 6 and 12 months' chronological age by the raised volume rapid thoracoabdominal compression technique. Measurements and Main Results: A total of 25% of participants had chorioamnionitis. Although infant pulmonary function testing variables were lower in infants born preterm compared with historical normative data for term infants, there were no differences between infants with chorioamnionitis (n = 20) and those without (n = 49). Boys and black infants had lower infant pulmonary function testing measurements than girls and white infants, respectively. Chorioamnionitis exposure was associated independently with wheeze (odds ratio [OR], 2.08) and respiratory-related physician visits (OR, 3.18) in the first year of life. Infants exposed to severe chorioamnionitis had increased levels of cord blood IL-6 and greater pulmonary morbidity at age 6 to 12 months than those exposed to mild chorioamnionitis. Elevated IL-6 was associated with significantly more respiratory problems (OR, 3.23). Conclusions: In infants born moderate or late preterm, elevated cord blood IL-6 and exposure to histologically identified chorioamnionitis was associated with respiratory morbidity during infancy without significant changes in infant pulmonary function testing measurements. Black compared with white and boy compared with girl infants had lower infant pulmonary function testing measurements and worse pulmonary outcomes.

KW - Asthma

KW - Fetal inflammation

KW - Fetal programming

KW - Infant pulmonary function test

KW - Wheeze

UR - http://www.scopus.com/inward/record.url?scp=84989306594&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84989306594&partnerID=8YFLogxK

U2 - 10.1513/AnnalsATS.201507-411OC

DO - 10.1513/AnnalsATS.201507-411OC

M3 - Article

C2 - 27015030

AN - SCOPUS:84989306594

VL - 13

SP - 867

EP - 876

JO - Annals of the American Thoracic Society

JF - Annals of the American Thoracic Society

SN - 2325-6621

IS - 6

ER -